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and white blood cell proportions; and similar study design. Of note,
previous analyses of blood samples fromMCCS participants showed
substantial replication of previously identified signals and discovered
highly replicable novel associations for other health risk factors such
as BMI (7), alcohol consumption (8), and tobacco smoking (9).
Taken together, our data and those presented in Mandaviya et al.
would mean that there is at best weak evidence for an association
between FFQ-derived intakes of folate and vitamin B-12 and DNA
methylation in peripheral blood. This suggests that blood DNA
methylation might not mediate, nor be a useful marker of, the
association between intake of these nutrients and disease risk and
shows the complexity of the one-carbon metabolism pathway in
terms of, e.g., the number of nutrients involved, their interactions,
and existing interindividual differences in nutrient absorption and
metabolism.
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Reply to P-A Dugué et al.
Dear Editor:
Mandaviya et al. have attempted to replicate our findings of the
association of folate and vitamin B-12 intake with differentially
methylated positions and differentially methylated regions (DMRs)
(1). They used a previously published data set, in which they
performed a similar study to investigate associations between one-
carbon nutrients (including folate and vitamin B-12) and DNA
methylation in peripheral blood, and could not replicate our findings
(2). They therefore concluded that there is weak evidence for
an association between intake of folate and vitamin B-12 and
differences in genome-wide DNA methylation in peripheral blood.
We welcome the effort of Dugué et al. and, in general, we agree with
the overall conclusion that there is at most weak association between
folate and vitamin B-12 intake and circulating DNA methylation
levels.
Nevertheless, we believe that there are large differences between
the study of Dugué et al. and ours, apart from the ones already
mentioned by Dugué et al. First, we used whole blood leukocytes
to measure DNA methylation, whereas Dugué et al. used either
peripheral blood mononuclear cells (PBMCs), buffy coats, or
dried blood spots. PBMCs are lymphocytes and monocytes and
lack granulocytes. Because DNA methylation patterns greatly vary
between different cell types and with varying cell-type proportions
(3), the results from Dugué et al.’s study and ours are difficult to
directly compare. Second, we conducted our study in population-
based cohorts and specifically excluded prevalent cancer of any type.
In contrast, the study from Dugué et al. consisted of multiple nested
case–control sets including cases with different forms of cancer. We
excluded subjects with cancer cases because they potentially change
dietary patterns in response to their disease (4) and have different
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methylation patterns in blood (5–7). Third, to investigate differential
methylation, we used the lowest compared with the highest tertiles
of dietary intakes, whereas Dugué et al. divided dietary intakes
into quintiles and used the lowest compared with the middle three
quintiles (to evaluate deficiency) and the highest compared with the
middle three quintiles (to evaluate excess).
Fourth, a further difference in analysis between Dugué et al.’s
study and ours is the fact that we include vitamin supplement
use (B-vitamins, multivitamins, or folic acid supplements) as a
covariate in both of our continuous and categorical models because
this could confound the association between dietary folate or
vitamin B-12 and DNA methylation. Dugué et al. did not use
this covariate owing to absence of these data. Although only
16% of the Melbourne Collaborative Cohort Study reported using
multivitamins, there might still be some impact to their results. Fifth,
concerning the replication of the DMRs, Dugué et al. attempted to
replicate our identified DMRs by a look-up of the single CpGs of
the DMRs. However, to replicate DMRs, they need to be analyzed
as a whole region together and, therefore, one can use tools that
are specific to finding DMRs in order to replicate a complete
region.
Lastly, we used the residual method to adjust for total energy
intake, whereas Dugué et al. used total energy intake as a covariate
in the model (standard multivariate method). In the residual method,
total energy intake is adjusted using linear regressionwith continuous
variables before dividing it into categories, whereas in the standard
multivariate model, total energy intake is adjusted insufficiently
owing to categorical variables and loss of individuals by excluding
quantiles, leading to a decrease in power (8). Therefore, the
residual method is considered more optimal when using categorical
models.
We believe that it is worthwhile to replicate our results by using
similar analytic approaches, sample types, cohort types (controls
without cancer prevalence of any type), and covariates in both
studies. However, with all the efforts and evidence we have to date,
we agree that there seems to be little association between dietary
intake of folate or vitamin B-12 and DNA methylation.
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